Novo Nordisk shares plunge to four-year low after Alzheimer’s drug trial fails to hit key target

by | Nov 24, 2025 | news, Top News

Shares of Novo Nordisk plunged after the Danish pharmaceutical company said a highly anticipated trial for Alzheimer’s disease failed to meet its main goal.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments